PREDICTORS OF CLINICAL OUTCOMES IN INDIAN PATIENTS WITH ACUTE ENCEPHALOPATHY: A PROSPECTIVE OBSERVATIONAL STUDY FROM A TERTIARY CARE CENTER IN INDIA

Authors

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i3.44052

Keywords:

Brain diseases, Central nervous system, India, Meningitis, Neuroimaging, Observational study

Abstract

Objective: Objective of the study was to evaluate the predictors of poor disease outcome at discharge and at 1 month in patients with acute encephalopathy.

Methods: This prospective, observational, single center study included adult patients meeting the diagnostic criteria for acute confusion state and admitted in the intensive care unit of a tertiary care hospital. A modified Rankin Scale (mRS) score of <3 was considered as “good outcome,” while mRS ≥3 was considered as an indicator of “poor outcome.”

Results: Among the total population of 219, 52.5% (n=115) were male, the mean age was 41.58 (±18.10) years and mean disease duration was 14.30 (±10.05) days (range: 1–30 days). Lethargy was the most common history at presentation (84.93%), while sleep abnormalities were least common (4.57%), and tuberculous meningitis was the most common etiology (21%). Diminution of vision, diplopia, dysarthria, cranial nerve symptoms, abdominal pain, difficulty in breathing, seizures, high-risk behavior, loss of appetite and the diagnosis of posterior reversible encephalopathy, retroviral disease, stroke and tuberculous meningitis were significant predictors of “poor outcome” at discharge (p<0.05). A diagnosis of tuberculous meningitis, history of headache, diminution of vision, diplopia, dysarthria, seizures, sensory deficits and loss of appetite and neuroimaging findings of atrophy, intracranial bleeding, demyelination, and space-occupying lesion were found to be significant predictors of “poor outcome” at 1 month post-discharge in this population (p<0.05).

Conclusion: In patients with acute encephalopathy, tuberculous etiology, the presence of focal brainstem deficits and specific neuroimaging findings indicate poor outcomes at discharge as well as at 1 month follow-up.

Downloads

Download data is not yet available.

References

Erkkinen MG, Berkowitz AL. A clinical approach to diagnosing encephalopathy. Am J Med 2019;132:1142-7.

Sutter R, Kaplan PW. What to see when you are looking at confusion: A review of the neuroimaging of acute encephalopathy. J Neurol Neurosurg Psychiatry 2015;86:446-59.

Bhalla A, Suri V, Varma S, Sharma N, Mahi S, Singh P, et al. Acute febrile encephalopathy in adults from Northwest India. J Emerg Trauma Shock 2010;3:220-4.

Salluh JIF, Wang H, Schneider EB, Nagaraja N, Yenokyan G, Damluji A, et al. Outcome of delirium in critically ill patients: Systematic review and meta-analysis. BMJ 2015;350:h2538.

Wong CL, Holroyd-Leduc J, Simel DL, Straus SE. Does this patient have delirium? JAMA 2010;304:779-86.

Modi A, Atam V, Jain N, Gutch M, Verma R. The etiological diagnosis and outcome in patients of acute febrile encephalopathy: A prospective observational study at tertiary care center. Neurol India 2012;60:168-73.

Guibo F, Zhou L, Li F, Hu Y, Wang X, Tian X. Predictors of outcome in clinically diagnosed viral encephalitis patients: A 5-year prospective study. Biomed Res Int 2020;2020:2832418.

Schubert J, Brämer D, Huttner HB, Gerner ST, Fuhrer H, Melzer N, et al. Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurol Neuroimmunol Neuroinflamm 2019;6:e514.

Qiu X, Zhang H, Li D, Wang J, Jiang Z, Zhou Y, et al. Analysis of clinical characteristics and poor prognostic predictors in patients with an initial diagnosis of autoimmune encephalitis. Front Immunol 2019;10:1286.

Sutter R, Kaplan PW. Neuroimaging correlates of acute encephalopathy. J Clin Neurophysiol 2013;30:517-25.

Chaudhry N, Duggal AK. Sepsis associated encephalopathy. Adv Med 2014;2014:762320.

Published

07-03-2022

How to Cite

S, M., S. S, and R. N. “PREDICTORS OF CLINICAL OUTCOMES IN INDIAN PATIENTS WITH ACUTE ENCEPHALOPATHY: A PROSPECTIVE OBSERVATIONAL STUDY FROM A TERTIARY CARE CENTER IN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 3, Mar. 2022, pp. 42-46, doi:10.22159/ajpcr.2022.v15i3.44052.

Issue

Section

Original Article(s)